Our Focus

Our recent data in mouse melanoma model demonstrates the ability of AVM0703 preconditioning to enhance CarT reduction of melanoma tumor volume as much as chemotherapy preconditioning. 

Lymphoablation can cure autoimmune diseases. AVM0703 lymphoablates equivalently to toxic chemotherapy with recovery observed in only 7-14 days, reducing the need for transfusion and infection risk. Therefore, treatment costs are dramatically reduced.